The UiPath Paradox: Why Good Numbers Triggered a Market Panic

Posted on by

(SeaPRwire) –   By: Lucas Caldwell

The market is sending a brutal signal to UiPath right now. A 7.7% drop on incredibly thin volume screams that confidence is evaporating faster than revenue can actually grow. Investors are actively ignoring the solid numbers posted recently. They see a deeper structural problem in the automation hype cycle. The stock is bleeding out near its yearly lows. This is not just a standard market correction. It is a painful re-evaluation of the entire RPA thesis. The bots might be working, but the institutional money is clearly leaving the building.

Let’s look at the hard data driving this pain. PATH hit an intraday low of $11.00 on Wednesday. It eventually closed at $11.11, down significantly from the prior close of $12.04. The volume was shockingly low at just 6.4 million shares. That figure is roughly 85% below the average session volume of 41.4 million. The 50-day moving average sits exactly at $11.11. The 200-day average sits slightly higher at $11.75. The current market cap is roughly $5.50 billion. The price action is technically weak. The liquidity is rapidly drying up.

The fundamentals tell a completely different story. Revenue hit $418.38 million for the latest quarter. This number beat analyst estimates of $397.54 million. It represents a solid 17.3% year-over-year growth rate. EPS came in at $0.15, matching consensus perfectly. Net margin was reported at 19.58%. Return on equity stood at 7.92%. Analysts expect $0.40 EPS for the full fiscal year. Convergence Investment Partners bought a new $4.4 million position in Q1. Institutions collectively own 62.50% of the company.

Wall Street is clearly skeptical of the future trajectory. Fourteen analysts rate it a “Hold”. Only two are brave enough to say “Buy”. The consensus price target is $13.80. BMO Capital Markets cut its target to $13. Morgan Stanley trimmed theirs to $15. UBS dropped their target to $12. Even Bank of America raised a target to $13 but kept an “underperform” rating. Only Needham stays bullish with a $15 target. The smart money is aggressively hedging. They see growth slowing down. They fear the AI wave might crush legacy RPA players.

The disconnect between earnings and price is alarming. The stock is well below its 52-week high of $19.84. It is hovering just above the 52-week low of $9.20. Beating estimates used to drive this stock up significantly. Now it triggers a sell-off. The low volume suggests few buyers are stepping in to catch the falling knife. This creates a fragile floor for the asset. If support breaks at $11, the next stop is much lower. The market is pricing in a stagnation that the income statement does not yet show.

UiPath is becoming a value trap in a high-growth disguise.

Author bio: Lucas Caldwell, a tech opinion leader with millions of followers on X/Twitter.